Insights

Growing Allergy Market ALK operates within the global allergy treatment market, which is experiencing increasing demand due to rising prevalence of respiratory and food allergies worldwide. This presents significant sales opportunities for innovative allergy solutions and formulations aimed at both healthcare providers and consumers.

Global Presence Expansion With manufacturing sites in Denmark, France, Spain, and the United States, ALK’s established international footprint provides a platform for expanding sales channels, entering new markets, and forming strategic partnerships to enhance distribution of allergy treatments across diverse regions.

Digital Engagement Tools ALK’s utilization of advanced technology such as Pardot and SCADA indicates a focus on digital marketing and operational efficiency, offering opportunities to develop targeted outreach, telehealth solutions, or digital health monitoring products tailored to allergy patients.

Financial Stability With revenues between one and ten billion dollars and a substantial employee base, ALK demonstrates financial stability, making it a compelling partner for co-developing new allergy therapies, investing in R&D, or expanding product lines within the allergy and immunology sectors.

Innovative Safety Focus The recent appointment of a vice president for safety and security reflects ALK’s commitment to high safety standards, opening pathways for solutions in patient safety, compliance, and secure health data management, which are critical for healthcare providers and regulatory bodies.

ALK Tech Stack

ALK uses 8 technology products and services including LinkedIn Ads, Veeam, SCADA, and more. Explore ALK's tech stack below.

  • LinkedIn Ads
    Advertising
  • Veeam
    Backup And Recovery
  • SCADA
    Control Systems
  • Apple iCloud Mail
    Email
  • Microsoft Active Directory
    Identity And Access Management
  • Underscore.js
    Javascript Libraries
  • Pardot
    Marketing
  • X-XSS-Protection
    Security

Media & News

ALK's Email Address Formats

ALK uses at least 1 format(s):
ALK Email FormatsExamplePercentage
First.Last@alk.netJohn.Doe@alk.net
84%
FLast@alk.netJDoe@alk.net
8%
FirstLas@alk.netJohnDoe@alk.net
5%
First.Middle.Last@alk.netJohn.Michael.Doe@alk.net
3%

Frequently Asked Questions

What is ALK's stock symbol?

Minus sign iconPlus sign icon
ALK is a publicly traded company; the company's stock symbol is ALK.

What is ALK's official website and social media links?

Minus sign iconPlus sign icon
ALK's official website is alk.net and has social profiles on LinkedIn.

How much revenue does ALK generate?

Minus sign iconPlus sign icon
As of December 2025, ALK's annual revenue is estimated to be $703M.

What is ALK's SIC code NAICS code?

Minus sign iconPlus sign icon
ALK's SIC code is 2830 - Drugs NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ALK have currently?

Minus sign iconPlus sign icon
As of December 2025, ALK has approximately 2.9K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo & President: P. H.Chief Executive Officer: C. S.Ceo: U. M.. Explore ALK's employee directory with LeadIQ.

What industry does ALK belong to?

Minus sign iconPlus sign icon
ALK operates in the Pharmaceutical Manufacturing industry.

What technology does ALK use?

Minus sign iconPlus sign icon
ALK's tech stack includes LinkedIn AdsVeeamSCADAApple iCloud MailMicrosoft Active DirectoryUnderscore.jsPardotX-XSS-Protection.

What is ALK's email format?

Minus sign iconPlus sign icon
ALK's email format typically follows the pattern of First.Last@alk.net. Find more ALK email formats with LeadIQ.

When was ALK founded?

Minus sign iconPlus sign icon
ALK was founded in 1923.

ALK

Pharmaceutical ManufacturingDenmark1001-5000 Employees

We are the pioneers of allergy solutions. Allergy is the most common chronic disease globally and it has profound impact on people’s lives. More than 500 million people worldwide live with respiratory allergies, more than 200 million people have some sort of food allergy, and more than 100 million children are living with allergic rhinitis. These numbers are only expected to increase, and as a result, the need for allergy solutions is ever-growing.

For more than a 100 years, ALK has been at the forefront of long-term allergy treatment. Building on our strong heritage, we are now stepping into the next 100 years with a mission to help even more people, with more solutions, more efficiently. We call it Allergy+.

ALK is a global company with production sites in Denmark, France, Spain and the United States. ALK was founded in Copenhagen in 1923 and today we employ around 2,900 people around the world. Our global headquarters is located in beautiful surroundings in Hørsholm, north of Copenhagen.

Read more about ALK at www.alk.net

Section iconCompany Overview

Website
alk.net
SIC Code
2830 - Drugs
Stock Symbol
ALK
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1923
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    ALK's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    ALK's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.